🔎 Trials Near Me

Utama › Leukemia Limfositik Kronik › Utah › Salt Lake City

Kajian klinikal Leukemia Limfositik Kronik di Salt Lake City, UT

10 kajian untuk Leukemia Limfositik Kronik sedang mencari peserta di lokasi dalam dan sekitar Salt Lake City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Mengambil pesertaFasa 3
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT04269902

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Mengambil pesertaFasa 3
  • Huntsman Cancer Institute, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277231

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Mengambil pesertaFasa 2
  • University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07221500

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Mengambil pesertaFasa 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07061951

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Mengambil pesertaFasa 1
  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05091424

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Mengambil pesertaFasa 1
  • University of Utah, Salt Lake City
Umur 13 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT04771572

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

Mengambil pesertaFasa 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT05183854

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Mengambil pesertaFasa 1
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT04830137

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Mengambil pesertaFasa 2
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Dis 2025 · NCT04844528

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Mengambil pesertaFasa 1/2
  • University of Utah, Salt Lake City
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Nov 2025 · NCT05643742

Kajian Leukemia Limfositik Kronik di bandar lain

Kajian lain di Salt Lake City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.